NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported exceptional financial results for fourth-quarter and full-year 2022 and provided 2023 financial guidance (4). The fourth-quarter 2022 ...

Good day, everyone, and welcome to Pfizer’s Fourth Quarter 2022 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior ...

Pfizer sold $37.8 billion of its Covid vaccine last year, a small increase of 3% compared with 2021 as demand for the shots slowed. Sales of Paxlovid, however, surged to $18.9 billion in 2022, which ...

Super Bowl ads are a show within the show, an opportunity for brands and advertising creatives to put their work in front of more than 100 million viewers. And while the occasion is most closely ...

On Tuesday, Pfizer Inc. (NYSE:PFE) reported second-quarter adjusted EPS of $0.60, down 11% year over year, beating the consensus of $0.46. The U.S. drugmaker reported sales of $13.28 billion, up 2% ...

Lady Gaga's new Instagram promo has caused controversy online, with fans dubbing the singer a "Big Pharma sellout." On April 9, the pop star—born Stefani Germanotta—shared her latest commercial with ...

Second-quarter 2024 Comirnaty revenues of $195 million declined 87%. Paxlovid revenues increased 79% to $251 million. Vyndaqel family drugs generated sales of $2.46 billion, up 68%. Eliquis, a blood ...